Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Abbott Laboratories is a healthcare giant with products ... In recent years, its FreeStyle Libre franchise of continuous glucose monitoring (CGM) systems -- which help diabetics keep track of ...

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede growth. The stock carries a Zacks Rank #4 (Sell) currently. A challenging ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

In June, Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not ...

In this article, we will be taking a look at the 7 best dialysis and kidney disease stocks to buy. Global Kidney Treatment ...

According to Allied Market Research, in 2020, the market was valued at $91.2 billion and is projected ... from its last price of $354.94. Abbott Laboratories (NYSE:ABT) ranks sixth among the ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

That is the case for two healthcare giants: Abbott Laboratories (NYSE ... franchise, the FreeStyle Libre. It has been its best-performing device for years, but as Abbott reported earlier this ...

Thursday, Abbott Laboratories (NYSE:ABT) said it is recalling some FreeStyle Libre 3 sensors after finding ... Continuous ...